Sale!

Intravenous Immunoglobulins In The Third Millennium 1st Edition by Marinos Dalakas, Peter Spath ISBN 1842142585 978-1842142585

Original price was: $50.00.Current price is: $35.00.

Intravenous Immunoglobulins In The Third Millennium 1st Edition Marinos C. Dalakas Digital Instant Download

Author(s): Marinos C. Dalakas, Peter Spath
ISBN(s): 9781842142585, 1842142585
Edition: 1
File Details: PDF, 3.23 MB
Year: 2003
Language: english
SKU: EB-2139914 Category: Tags: ,

Intravenous Immunoglobulins In The Third Millennium 1st Edition by  Marinos C. Dalakas, Peter Spath- Ebook PDF Instant Download/Delivery: 1842142585, 978-1842142585
Full download Intravenous Immunoglobulins In The Third Millennium 1st Edition after payment

Product details: 

ISBN 10: 1842142585 

ISBN 13: 978-1842142585

Author: Marinos C. Dalakas, Peter Spath

Intravenous Immunoglobulins In the Third Millennium is a highly authoritative review of the pharmacology and therapeutic use of these agents. Based on the famous Interlaken IVIG International Symposium held every five years, and written by an internationally recognized team of expert scientists and clinicians, the book reviews the major challenges and achievements in manufacturing, pathogen safety, clinical use and mechanisms of action of IVIG and highlights the major recent and ongoing research in the field. This comprehensive update will become a valuable source of information for all who are interested in the various aspects of IVIG.
 

Table of contents: 

Two decades of experience with intravenous immunoglobulin

1. Manufacturing of intravenous immunoglobulin: challenges, achievements and opportunities

A.Morell

2. Challenges and achievements in pathogen safety of intravenous immunoglobulin

P.J.Späth and C.Kempf

3. Treatment modalities and clinical efficacy of immunoglobulin G replacement therapies in primary immunodeficiency

A.D.B.Webster

4. Immunomodulation by intravenous immunoglobulin: idiopathic thrombocytopenic purpura as a model

P.Imbach

5. Witnessing the introduction and use of intravenous immunoglobulin in neurology

M.C.Dalakas

6. Pharmacoeconomics of intravenous immunoglobulin administration in neurological disorders: the US experience

P.D.Donofrio

7. Pharmacoeconomics of intravenous immunoglobulin for polyneuropathies

P.McCrone

Intravenous immunoglobulin in immunodeficiencies and severe infections-molecular aspects and clinical use

8. B-cell maturation to produce high-affinity antibodies of different isotypes and its abnormalities

A.Durandy

9. The molecular basis of primary immune deficiency diseases

H.D.Ochs, T.R.Torgerson, W.-I.Lee, Y.Z..Jin, E.Gambineri and Q.Zhu

10. Safety in intravenous immunoglobulin therapy

E.W.Gelfand

11. Immunoglobulin replacement by the subcutaneous route using preparations licensed in the USA for administration by other routes

M.Berger, K.Duff, J.Poll and S.Roy

12. The use of intravenous immunoglobulin for allogeneic stem cell transplantation: the US experience

R.H.Buckley

13. Intravenous immunoglobulin for bone marrow/stem cell transplantation: the European experience

K.Theunissen, J.A.Maertens and M.A.Boogaerts

14. Secondary antibody deficiency following treatment of vasculitis: the use of

intravenous immunoglobulin

V.J Tormey and A.Burns

15. Intravenous immunoglobulin in the prevention and treatment of severe

infections

K. Werdan

Immunomodulatory and anti-inflammatory potential of intravenous immunoglobulin

16. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases

M.D.Kazatchkine, J.Bayry, S.Lacroix-Desmazes and S.V.Kaveri

17. Role of intravenous immunoglobulin in reversing glucocorticoid insensitivity or resistance

E.W.Gelfand

18. Modulating the balance of activating and inhibiting Fcy receptors: mechanism of intravenous immunoglobulin action

L. Pricop

19. Anti-inflammatory effects of intravenous immunoglobulin: Fcy receptor inhibition/blockade and non-Fcy receptor-mediated mechanisms

J.W.Semple and A.H.Lazarus

20. Immune modulation by intravenous immunoglobulin: some remarks on the role of Fc receptors

E.van Mirre and C.E.Hack

21. Intravenous immunoglobulin in reactive hemophagocytic syndrome: a paradigm of Fcy receptor and cytokine modulation

L.Mouthon

22. Anti-inflammatory effects of intravenous immunoglobulin through modulation of complement activities

H.U.Lutz and P.J.Späth

23. Changes in gene expression profile in the muscles of patients with dermatomyositis and inclusion body myositis after therapy with intravenous immunoglobulin: a microarray analysis correlating gene expression with clinical outcome

R.Raju and M.C.Dalakas

24. In vitro studies of mechanisms of action of intravenous immunoglobulin in Guillain-Barré syndrome and Miller-Fisher syndrome: a review

R.Gold, A. Weishaupt, M.Stangel, A.Chan and K.V.Toyka

Intravenous immunoglobulin for autoimmune diseases of the peripheral nervous system

25. Theimmunological rationale for intravenous immunoglobulin in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

J.D. Pollard

26. Intravenous immunoglobulin for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy in adult patients

P.A.van Doorn

27. Clinical experience with intravenous immunoglobulin for treatment of pediatric Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

A..J.Kornberg

28. Intravenous immunoglobulin for multifocal motor neuropathy

L.H.van den Berg

29. Intravenous immunoglobulins in paraproteinemic demyelinating neuropathies

J.-M.Léger

30. Immunoglobulins in IgM antimyelin-associated glycoprotein and other

paraproteinemic neuropathies

G.Comi

31. Intravenous immunoglobulin for myasthenia gravis

P.Gajdos

32. Intravenous immunoglobulin in polymyositis and dermatomyositis

P.Chérin

33. Controlled studies with high-dose intravenous immunoglobulin in the treatment of inclusion body myositis

M.C.Dalakas

Intravenous immunoglobulin for autoimmune diseases of the central nervous system

34. Immune mechanisms and treatment perspectives in multiple sclerosis

R.Hohlfeld

35. A review of controlled clinical trials of intravenous immunoglobulin in multiple sclerosis

P.S.Sorensen

36. Intravenous immunoglobulin treatment for patients with primary or secondary progressive multiple sclerosis

D. Pöhlau and U.Kallweit

37. What is the effective dose of intravenous immunoglobulin for treatment of

relapsing-remitting multiple sd erosis?

M.Lewanska, M.Siger-Zajdel and K.Selmaj

38. High-dose intravenous immunoglobulin in the treatment of patients with stiff person syndrome: a controlled study

M.C.Dala

39. Intravenous immunoglobulin in acute disseminated encephalomyelitis

E.Marchioni, S.Ravaglia, A. Todeschini, A.Pichiecchio, C.Uggetti, G.Piccolo

and M. Ceroni

The use of intravenous immunoglobulin in dermatology

40. Intravenous immunoglobulin in dermatology

S. Jolles

41. The use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases

A.R.Ahmed

42. Treatment of atopic dermatitis, urticaria and psoriasis with intravenous

immunoglobulin

M.Rustin

43. Intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-

Johnson syndrome

L.E.French

44. Intravenous immunoglobulin in the treatment of vasculitis

D..Jayne

People also search for:

intravenous infusion of immunoglobulins
    
use of intravenous and subcutaneous human immunoglobulins
    
what are intravenous immunoglobulins
    
what are iv immunoglobulins
    
how does intravenous immunoglobulin work

Tags: Marinos Dalakas, Peter Spath, Intravenous Immunoglobulins, The Third Millennium